Skip to main content
Advertising

Originally published Wednesday, August 13, 2014 at 5:57 PM

  • Share:
           
  • Comments
  • Print

FDA approves new sleeping drug from Merck

Merck & Co. has won federal approval for a new type of sleeping pill designed to help people with insomnia stay asleep.


advertising

WASHINGTON —

Merck & Co. has won federal approval for a new type of sleeping pill designed to help people with insomnia stay asleep.

The tablet, Belsomra, works by temporarily blocking chemicals known as orexins that control the sleep cycle and can keep people awake at night. It's unclear whether the new drug is safer or more effective than older drugs because it was tested against a dummy pill, rather than other sleeping medications.

The Food and Drug Administration approved the drug in four different doses for various degrees of insomnia. The agency notes that patients who took the highest dose, 20 milligrams, experienced drowsiness and difficulty driving the following morning. The FDA says doctors should warn patients taking that dose against next-day driving or activities that require full concentration.



Want unlimited access to seattletimes.com? Subscribe now!

Also in Business & Technology

News where, when and how you want it

Email Icon

Want free career advice? And an iPad Mini?

Want free career advice? And an iPad Mini?

Tell us about your goals and challenges and be considered for a future NWjobs career-makeover story, as well as a chance to win an iPad Mini!

Advertising

Advertising


Advertising
The Seattle Times

The door is closed, but it's not locked.

Take a minute to subscribe and continue to enjoy The Seattle Times for as little as 99 cents a week.

Subscription options ►

Already a subscriber?

We've got good news for you. Unlimited seattletimes.com content access is included with most subscriptions.

Subscriber login ►
The Seattle Times

To keep reading, you need a subscription upgrade.

We hope you have enjoyed your complimentary access. For unlimited seattletimes.com access, please upgrade your digital subscription.

Call customer service at 1.800.542.0820 for assistance with your upgrade or questions about your subscriber status.

The Seattle Times

To keep reading, you need a subscription.

We hope you have enjoyed your complimentary access. Subscribe now for unlimited access!

Subscription options ►

Already a subscriber?

We've got good news for you. Unlimited seattletimes.com content access is included with most subscriptions.

Activate Subscriber Account ►